These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 3929499

  • 21. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N.
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [Abstract] [Full Text] [Related]

  • 22. [Relation between hyperprolactinemia and polycystic ovary syndrome].
    Hámori M, Szendei G, Kovács I, Somos P.
    Zentralbl Gynakol; 1987 Jan; 109(8):481-6. PubMed ID: 3111126
    [Abstract] [Full Text] [Related]

  • 23. [Changes in the prolactin level under the effect of pulsatile infusion of gonadotropin releasing hormone].
    Koloszár S, Bártfai G, Sas M.
    Orv Hetil; 1989 Jul 02; 130(27):1433-6. PubMed ID: 2501725
    [Abstract] [Full Text] [Related]

  • 24. Qualitative abnormal gonadotropin secretion in anorexia nervosa.
    Ceda GP, Valenti G, Speroni G, Butturini U.
    Acta Eur Fertil; 1981 Sep 02; 12(3):277-9. PubMed ID: 6803499
    [No Abstract] [Full Text] [Related]

  • 25. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
    Djursing H, Hagen C, Nyholm HC, Carstensen L, Andersen AN.
    J Clin Endocrinol Metab; 1983 May 02; 56(5):1016-21. PubMed ID: 6403566
    [Abstract] [Full Text] [Related]

  • 26. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
    Rjosk HK, Werder K, Fahlbusch R.
    Geburtshilfe Frauenheilkd; 1976 Jul 02; 36(7):575-87. PubMed ID: 986336
    [Abstract] [Full Text] [Related]

  • 27. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME, Judd SJ, Gilliland GB, Yen SS.
    J Clin Endocrinol Metab; 1979 Apr 02; 48(4):718-20. PubMed ID: 429515
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM, Ruiz AE, Banks WA.
    Horm Res; 1991 Apr 02; 35(3-4):167-9. PubMed ID: 1806471
    [Abstract] [Full Text] [Related]

  • 30. Identification of a silent pituitary somatotropic adenoma based on a paradoxic response of growth hormone on a thyrotropin-releasing hormone or gonadotropin-releasing hormone provocation test.
    Matsuno A, Ogino Y, Katayama H, Osamura RY, Nagashima T.
    Am J Obstet Gynecol; 2001 Feb 02; 184(3):286-8. PubMed ID: 11228475
    [Abstract] [Full Text] [Related]

  • 31. [Endocrine diagnosis of pituitary adenomas (author's transl)].
    Nakai Y, Oki S, Nakao K, Fukada J, Kinoshita F, Tanaka K, Tsukada T, Imura H.
    No To Shinkei; 1981 May 02; 33(5):431-40. PubMed ID: 6266437
    [No Abstract] [Full Text] [Related]

  • 32. A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors.
    Kletzky OA, Davajan V, Mishell DR, Nicoloff JT, Mims R, March CM, Nakamura RM.
    J Clin Endocrinol Metab; 1977 Oct 02; 45(4):631-40. PubMed ID: 410820
    [No Abstract] [Full Text] [Related]

  • 33. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY, Jarrett JC, Choe JK.
    Fertil Steril; 1982 Oct 02; 38(4):415-8. PubMed ID: 6811337
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
    Berezin M, Olchovsky D, Pines A, Tadmor R, Lunenfeld B.
    J Clin Endocrinol Metab; 1984 Dec 02; 59(6):1220-3. PubMed ID: 6436289
    [Abstract] [Full Text] [Related]

  • 36. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.
    Lamberts SW, Docter R, De Jong FH, Birkenhäger JC, Kwa HG.
    Fertil Steril; 1978 Mar 02; 29(3):287-90. PubMed ID: 346383
    [Abstract] [Full Text] [Related]

  • 37. Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women.
    Seki K, Kato K.
    J Clin Endocrinol Metab; 1985 Dec 02; 61(6):1138-41. PubMed ID: 3932450
    [Abstract] [Full Text] [Related]

  • 38. [Behavior of blood prolactin in secondary amenorrhea and in menstrual cycle disorders after gonadotropin releasing hormone and TRH administration].
    Moggi G, Chisci R, Giorgi G, Navalesi R, Giampietro O, Mazzotta A, Berti P, Dalle Luche A.
    Minerva Ginecol; 1977 Nov 02; 29(11):830-2. PubMed ID: 416401
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.